Our data show that cancer cell lines that are sensitive to ACSL3 knockdown are also sensitive to LPIAT1 knockdown, while others that are resistant to ACSL3 knockdown are also resistant to LPIAT1 knockdown (Supplementary Fig. 1D-1F and Supplementary Fig. 2B–2D). The gene discussed is ACSL3; the disease is cancer.